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Abstract
Calcium phosphate ceramics with specific physicochemical properties have been shown to induce de novo bone formation
upon ectopic implantation in a number of animal models. In this study we explored the influence of physicochemical
properties as well as the animal species on material-induced ectopic bone formation. Three bioceramics were used for the
study: phase-pure hydroxyapatite (HA) sintered at 1200uC and two biphasic calcium phosphate (BCP) ceramics, consisting of
60 wt.% HA and 40 wt.% TCP (b-Tricalcium phosphate), sintered at either 1100uC or 1200uC. 108 samples of each ceramic
were intramuscularly implanted in dogs, rabbits, and rats for 6, 12, and 24 weeks respectively. Histological and
histomorphometrical analyses illustrated that ectopic bone and/or osteoid tissue formation was most pronounced in BCP
sintered at 1100uC and most limited in HA, independent of the animal model. Concerning the effect of animal species,
ectopic bone formation reproducibly occurred in dogs, while in rabbits and rats, new tissue formation was mainly limited to
osteoid. The results of this study confirmed that the incidence and the extent of material-induced bone formation are
related to both the physicochemical properties of calcium phosphate ceramics and the animal model.
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Introduction
Bone defects caused by tumor resection, trauma, infection and
congenital anomalies remain an important challenge in the field of
orthopaedic and craniofacial surgery. Clinical treatment of such
defects involves the use of natural grafts, like autograft and
allograft, or synthetics [1,2]. Autograft is still considered the gold
standard for bone substitution, owning to the absence of
immunogenic reaction, excellent osteogenicity, osteoinductivity
and osteoconductivity. However, shortage of donor supply,
persistence of pain, nerve damage, fracture, infection and cosmetic
disability at the donor site remain important drawbacks. The use
of allograft, where availability is less of a problem, suffers from
clinical risks of disease transmission and immunogenic reaction.
Another major drawback of allograft is its inconsistent quality from
both a biological and a mechanical perspective [1,3].
Tissue engineering is defined as an interdisciplinary field that
applies the principles of engineering and life sciences toward the
development of biological substitutes that restore, maintain, or
improve tissue function or a whole organ [4]. Along with stem cell
therapy that is currently being used for the treatment of various
diseases and disorders [5–8], tissue engineering approaches have
been developed and tested for various clinical applications. In
orthopedics and cranio-maxillo-facial surgery, tissue engineering is
considered a promising method to replace the autograft and
allograft and it developed rapidly in the last two decades as a result
of progress in cell biology and material science research [9–11]. In
tissue engineering, constructs are built consisting of degradable
biomaterials that serve as scaffold and transplanted (stem) cells that
adhere, proliferate and differentiate on the scaffold, and, in some
cases, additional growth factors to control cell fate [12,13].
Independent of the cell sources used in bone tissue engineered
constructs, one always faces the challenges of limited cell
availability, and in the case of allogeneic cells, risk of infection,
immunogenic reaction and disease transmission [12]. Further-
more, the complex procedure of cell harvesting, expansion and
maintenance makes the tissue engineering time-, money- and
labor-consuming [3]. Cell survival and vascularization are
similarly challenging issues, especially when attempting to create
large tissue constructs, despite developments of various in vitro
bioreactors [14–17]. In 2004, Warnke et al. reported a novel
method for repairing a defect in human mandible by in vivo tissue
engineering, where the patient’s body served as a natural
bioreactor. By combining ceramic particles, recombinant human
Bone Morphogenetic Protein 7 (rh-BMP-7) and autologous bone
marrow cells inside a titanium mesh, a sufficiently large piece of
bone tissue was successfully grown inside the latissimus dorsi
muscle of the patient prior to transplantation to repair the
mandible defect [17,18].
Calcium phosphates ceramics are extensively used as natural
bone graft substitutes owning to their similarity to the mineral
phase of natural bone, absence of immunogenic reactions,
excellent biocompatibility and osteoconductive potential [19]. In
the past five decades, a large number of publications have also
shown osteoinduction by a range of calcium phosphate biomate-
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rials, demonstrated by de novo bone formation upon implantation
in ectopic sites, such as in the muscle of baboon [20–22], goat [23],
sheep [19,24–26], dog [21,27–30], rabbit [21,31,32], rat [28] and
mouse [33,34] and in the subcutis of dog [28,35], goat [36] and
mouse [32]. The osteoinductive properties of calcium phosphate
ceramics put forward a new idea for in vivo bone tissue
engineering in which bone graft could be constructed in vivo by
implanting osteoinductive calcium phosphate ceramics, without
the addition of growth factors and/or stem cells in the muscle or
subcutis of patient for several weeks, followed by the transplan-
tation of the formed tissue to repair the bone defect. By doing so,
the step in which cells from the patient are harvested becomes
unnecessary. To demonstrate the feasibility of this method, our
group has implanted an osteoinductive calcium phosphate ceramic
in the femoral muscle of dogs for 8 weeks, followed by
transplantation to a bone defect created unilaterally in the dog
mandible to simultaneously support a dental implant. 8 weeks after
transplantation, the graft fused well with the host bone, and a
satisfactory osseointegration was achieved between the implant
and the graft [37]. It has furthermore been shown that
osteoinductive ceramics have the potential to complete the process
of regeneration of large, critical-sized bone defects as successfully
as autograft can [24], suggesting that even the step of intramus-
cular implantation prior to transplantation to bone defect may not
be needed.
Osteoinduction of a great number of materials has been studied
in the past five decades, using different animal species, however
the exact parameters influencing and mechanisms governing
ectopic bone formation are still not fully understood. It is suggested
that the important parameters for successful osteoinduction are (1)
chemical composition of the material and related dissolution
properties, which create a microenvironment rich in calcium and
phosphate ions; (2) geometry (i.e. porosity, interconnectivity and
pore size), which aid nutrition and oxygen supply and recruitment
of stem cells; (3) surface topography and micropores, which
determines the specific surface area and affects the osteogenic
differentiation of undifferentiated cells either directly (adhesion
mediated differentiation) or indirectly (via adsorption/precipita-
tion of relevant endogenous proteins); (4) the species and genetic
background of animal models; and (5) implantation site
[21,23,24,38–42].
Previous studies have demonstrated that osteoinduction by
biomaterials predominantly occurs in large animals [19–36,39,43],
while in small animals the incidence of ectopic bone formation is
relatively low [32–34]. The reason for these differences between
animal species is still unclear. Experiments in large animal models
are associated with issues of limited availability, high cost and
ethical concerns, which is why studies in large animals usually
involve relatively small sample size, limiting their reliability.
Testing osteoinductivity of biomaterials in small animals, such as
mice and rats, would not only allow studies with a large sample
size, but it would also enable more in-depth immunohistochemical
analyses which are readily available for studies in small animals.
Such in-depth analyses could provide more insight in biological
mechanisms governing bone induction by synthetic biomaterials.
The aim of this study was to determine material parameters that
are essential for osteoinduction to occur. In addition, this study is
aimed at investigating influence of species on material-induced
ectopic bone formation, as an attempt to find most suitable model
for this type of studies.
Materials and Methods
Preparation and characterization of the ceramics
Raw materials as well as final calcium phosphate ceramic
scaffolds were provided by the National Engineering Research
Center for Biomaterials (Chengdu, Sichuan, China). Briefly, the
ceramics were prepared in house using wet precipitation and
H2O2 foaming method, respectively, as previously described [37].
Hydroxyapatite (HA) was sintered at 1200uC (HA1200) and
biphasic calcium phosphate (BCP), consisting of 60 wt.% HA and
40 wt.% b-tricalcium phosphate (TCP) was sintered at either
1100uC (BCP1100) or 1200uC (BCP1200) for 3 hours. Ceramic
cylinders with dimensions Q5 mm68 mm, Q4 mm66 mm and
Figure 1. XRD patterns of the three ceramics. The patterns of BCP1100 and BCP1200 demonstrated biphasic nature of the ceramics consisting
of HA and b-TCP. No apparent differences were found as a result of difference in sintering temperature. The pattern of HA1200 was typical of phase-
pure hydroxyapatite.
doi:10.1371/journal.pone.0107044.g001
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Q2 mm63 mm intended for implantation in dogs, rabbits and
rats, respectively were cut and cleaned in ultrasonic baths. The size
of implants varied per animal model as to adapt to the size of the
implantation site. All the samples were sterilized by autoclaving
before implantation. The chemical composition of the ceramics
was analyzed by X-ray diffraction (XRD, Miniflex, Rigaku,
Japan). The ultrastructure and the surface microstructure of the
ceramics were investigated using scanning electron microscopy
(XL30 ESEM FEG, Philips, The Netherlands). For quantification
of the average macropore size and macroporosity, ceramic blocks
(n = 8) were embedded in methylmethacrylate (MMA), and
allowed to polymerize, after which 10–20 mm thick sections were
cut using a diamond saw (Leica, Germany). Semi-automated
measurements were performed using a light microscope (Nikon,
Japan, Objective610), connected to a KS400 imaging system
(Carl Zeiss, Germany).
Animal experiments
The experimental protocol was approved by the Animal Care
and Use Committee of Sichuan University. To determine the
minimum sample size needed to obtain statistical differences
between animal species and three types of materials, the sample
sizes were estimated by applying the equation for comparative
studies [44]. Surgery was performed on 27 mongrel dogs (10–
15 kg, male), 36 New Zealand white rabbits (2.5–3.0 kg, male) and
54 S.D. rats (200–250 g, male) at the Experimental Animal Centre
of Sichuan University. After anesthesia of the animals with 3%
sodium pentobarbital (Sigma Chemical, St. Louis, MO, USA), the
operation sites were shaved and the skin was sterilized with iodine.
A longitudinal incision (10 cm, 5 cm and 2 cm in dogs, rabbits
and rats, respectively) was created and the muscles were exposed
by blunt separation. The muscle incisions were made by scalpel
and the separated intramuscular pockets of appropriate size, with
a distance of approximately 1 cm from one another were created
by blunt separation. Each pocket received a single ceramic
implant, after which the wound was closed in layers by using silk
suture. After surgery, penicillin was administered intramuscularly
for 3 consecutive days to prevent infection. In total 108 samples of
each ceramic was implanted in each of the three species: four
cylinders (Q5 mm68 mm) of each ceramic type were implanted in
the dorsal muscle of each dog, three cylinders (Q4 mm66 mm)
were implanted in the dorsal muscle of each rabbit, and two
cylinders (Q2 mm63 mm) of each ceramic were implanted in the
femoral muscle of each rat. Animals were sacrificed by an
overdose of sodium pentobarbital 6, 12 or 24 weeks post-
implantation in a randomized manner. These survival times were
selected based on earlier studies on ectopic bone formation by
synthetic biomaterials [34].
Retrieval of implants, histology, and histomorphometry
At explantation, the samples were collected with surrounding
tissues and fixed in 4% buffered formaldehyde solution. The fixed
samples were then decalcified in 10% ethylene diamine tetraacetic
acid (EDTA) for 15 days and washed with phosphate buffer
solution (PBS), dehydrated with gradient of ethanol solutions at
70%, 80%, 90%, 95% and 100%62, and then embedded in
paraffin. Continuous 5 mm sections were made parallel to the long
axis of the implants and then stained with hematoxylin and eosin
Figure 2. SEM micrographs showing macrostructure (A–C) and surface microstructure (D–F) of BCP1100 (A,D), BCP1200 (B,E) and
HA1200 (C,F). All ceramics were porous with similar macroporous structure (A–C). The surface of the BCP1100 (D) ceramic exhibited smaller grains
and a larger number of micropores than the chemically identical BCP1200, that was sintered at 1200uC (E). Grain size and number of micropores in
HA1200 were between those of BCP110 and BCP1200 (F), which is in accordance with specific weight measurements in Table 1. Scale bar = 1 mm for
A–C and 10 mm for D–F.
doi:10.1371/journal.pone.0107044.g002
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(HE) (for all time points) or Masson’s trichrome staining (for 12
weeks, which is representative for other time points) for histological
analysis. Occurrence of osteoid tissue formation was assessed by
three experienced pathologists separately without knowledge of the
source of the specimens.
Histomorphometry was performed on 25 randomly selected
fields at a magnification 106 (objective) of a single section taken
from the middle of each implant, by using a light microscope
(Nikon, Japan) coupled to a KS400 imaging system (Carl Zeiss,
Germany). The macropore area and the area of bone or osteoid
tissue were semi-automatically measured and the percentage of the
induced bone and osteoid tissue inside the macropores (b% and
o% respectively) were calculated. While b% was determined in all
samples in which ectopic bone formation was induced, o% was
determined in samples where osteoid, but no bone formation was
found. The reason for this is the fact that, while pathologist can
easily distinct between osteoid and bone, it is very difficult to draw
the line between the area where the osteoid stops and bone tissue
starts, making a reliable histomorphometry impossible to perform.
Therefore, in samples with both osteoid and bone, the total area
was used to calculate %b, whereas only the samples without bone
were used for calculating %o. This makes results on bone and
osteoid incidence and %b and %o complementary.
Statistical analysis
Light micrograph images were analyzed with IPP (Image-Pro-
Plus) software, and statistical analysis was performed on histo-
morphometry data using SPSS19.0. Pearson’s chi-square test was
conducted to compare the overall constituent ratios of bone and
osteoid tissue incidence in the three groups and differences with
p,0.05 were considered significant. The adjusted test of level (a’)
was used to compare the constituent ratios of each two groups and
the differences with p,0.017 were considered significant (Parti-
tions of chi-square method) with a’ = 2a/k(k–1) k = 3, a=0.05.
Results
Properties of the ceramics
The X-ray diffraction analysis (Fig. 1) of BCP1100 and
BCP1200 demonstrated biphasic nature of the ceramics and no
apparent differences were found as a result of difference in
sintering temperature. The pattern of HA1200 was typical of
phase-pure HA. The SEM analysis (Fig. 2) showed that all
ceramics were porous. The pore size of macropores in BCP1100,
BCP1200 and HA1200 were 380650 mm, 400650 mm and
400650 mm respectively. However at the temperature of
1100uC the surface of the BCP ceramics was rougher with more
micropores between the ceramic grains as compared to the
ceramic sintered at 1200uC (Fig. 2). Characterization of the three
ceramics is summarized in Table 1.
Histological and histomorphometrical analyses
There were no surgical complications and all samples were
retrieved. At retrieval, all implants were surrounded by well-
vascularized muscle tissue. No signs of an inflammatory tissue
response directly related to the implants were observed. Table 2
and figure 3 provide an overview of the osteoid and bone
incidence, as well as percentage of bone and osteoid tissue in the
pores after 6, 12 and 24 weeks of implantation in the three animal
species.
In rats, no bone formation was observed in any of the three
ceramics, independent of the implantation time. At 6 weeks, no
osteoid was observed in any of the three ceramics (Fig. 4A–C),
and similarly, HA1200 did not induce osteoid formation at the
later time points either (Fig. 5C or Fig. 6C). In HA1200, the
tissue in the pores was fibrous in nature, only containing fibroblast-
like cells (Fig. 4C, 5C and 6C). After 12 weeks of implantation, a
thin band of osteoid with some compacted cuboidal cells adjacent
to pore walls was observed in 9 out of 36 samples of BCP1100 and
in 2 out of 36 samples of BCP1200. The percentage of osteoid
tissue formation was relatively low (0.9660.31% for BCP1100 and
0.8360.16% for BCP1200 respectively). Only the difference
between HA1200 and the other two ceramics was statistically
significant (p,0.017). At 24 weeks, incidence of osteoid formation
was 7/36 (0.4060.23%) and 5/36 (0.3960.17%) in BCP1100 and
BCP1200, respectively, a difference that was not statistically
significant, while there was a statistical difference between
BCP1100 and HA1200 (Fig. 3A and Table 2).
Intramuscular implantation of the three ceramics in rabbits did
not lead to a pronounced ectopic bone formation. Limited amount
of bony tissue and bone trabeculae (1.260.8%) was only observed
in three BCP1100 samples from the 12-week group, all coming
from one animal (Fig. 5D and Table 2). Osteoid formation was
observed in the three ceramics at all time points, although the
incidence was strongly dependent on the material. In HA1200,
only few samples showed osteoid formation (1/36, 1/36 and 2/36
after 6, 12 and 24 weeks respectively), and the pores of the ceramic
were predominantly occupied by fibrous tissue containing
fibroblasts, neutrophils, lymphocytes and plasma cells (Fig. 4F,
5F and 6F). Osteoid incidence was 4/36, 26/36 and 13/36 for
BCP1100 and 2/36, 13/36 and 2/36 for BCP1200 after 6, 12 and
24 weeks respectively (Fig. 3B, 4D–E, 5D–E, 6D–E and
Table 2). In terms of osteoid incidence, no statistically significant
differences were observed among the three ceramics after 6 weeks
of implantation. BCP1100 showed a higher osteoid incidence than
BCP1200 and HA1200 at both 12 and 24 weeks (p,0.017).
Similar to bone incidence, in rabbits, the area percentage of
ceramic pores occupied by osteoid tissue was highest in BCP1100,
increasing from 0.4060.27% at week 6 to 1.5760.51% at 24
weeks, respectively. In BCP1200 and HA1200, the %o remained
below 2% at all time points, and considering the very low osteoid
Table 1. Physico-chemical characterization of biphasic calcium phosphate sintered at 1100uC (BCP1100), of biphasic calcium
phosphate sintered at 1200uC (BCP1200) and of phase-pure hydroxyapatite sintered at 1200uC (HA1200).
BCP1100 BCP1200 HA1200
Weight ratio HA/b-TCP 60/40 60/40 100/0
Macropore size (mm) 380650 400650 400650
Overall porosity (%) 70.8 65.2 66.9
Specific weight (g/cm3) 0.970 1.21 1.10
doi:10.1371/journal.pone.0107044.t001
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Figure 3. Incidence of bone and osteoid tissue formation in different animals (A–D) and percentage of bone area in pores of dogs
(E) at 6, 12 and 24 after implantation. Osteoid formation in rats was not observed at 6 weeks in any of the ceramics, while at 12 and 24 weeks,
only BCP ceramics showed signs of osteoid formation (A). In rabbits, all ceramics showed ectopic osteoid formation at all time points, with a highest
incidence at 12 weeks. At all time points, BCP1100 showed a higher osteoid incidence than BCP1200, which was again higher than osteoid incidence
in HA1200 (B). In dogs, osteoid formation was observed in all ceramics at all time points, except in HA1200 at 6 weeks. Like in rabbits, a decreasing
osteoid incidence was observed from BCP11 to BCP1200 to HA1200 (C). All ceramic showed ectopic bone formation in dogs at all time points (D)
following a trend that was similar to that of osteoid incidence (C). Quantification of % of ectopic bone formation in available pore area showed that,
in general, BCP1100 showed higher values than BCP1200 and HA1200; however, these differences were not statistically significant (E).
doi:10.1371/journal.pone.0107044.g003
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incidence, a statistical comparison of histomorphometrical data
was not sensible (Table 2).
In dogs, the incidence and the amount of osteoid and ectopic
bone were higher for all the ceramics as compared to tissue
formation found in rats and rabbits (Fig. 3C–D, 4G–I, 5G–I,
6G–I and Table 2). In the pores of all BCP1100 samples,
formation of de novo bone adjacent to the material surface was
observed as early as at 6 weeks, and bone incidence 36/36
remained at the later time points. With time, the bone appeared
more trabecular, with lacunae containing osteocytes (Fig. 4G–6G
and Fig. 7A). In BCP1200, pores were mainly filled with star-
shaped cells or thin, elongated cells at 6 weeks and bone trabeculae
were observed in a half of the samples (Fig. 4H). After 12 weeks,
bone trabeculae were observed in the pores of the ceramic in most
samples (27/36), with a layer of osteoblasts aligning bone (Fig. 5H
and Fig. 7B). At week 24, bone incidence further increased to
31/36 and maturation of the trabeculae and the formation of new
blood vessels, along with appearance of myeloid tissue were
observed (Fig. 6H). The osteoinductive potential of HA1200 was
the poorest among the three ceramics, without bone formation at
week 6, and with pores filled with fibrous tissue mainly consisting
of fibroblasts or fibroblast-like cells. Bone formation was observed
after 12 weeks in 10/36 samples (Fig. 5I and Fig, 7C) and
incidence further increased to 23/36 after 24 weeks (Fig. 6I).
Incidence of ectopic bone formation in BCP1100 was statisti-
cally higher than in HA1200 at all time points. Further, statistical
differences in bone incidence were observed between BCP1200
and HA1200, and also between BCP1100 and BCP1200 after 6
and 12 weeks. Regarding presence of osteoid tissue, HA1200
performed significantly poorer than the other two ceramics at all
time points, while no significant differences between BCP1100 and
BCP1200 were observed after 12 and 24 weeks of implantation.
In BCP1100, the percentage of bone in the pores increased
from 8.864.5% at week 6 to 13.764.3% at week 12 and
14.764.2% after 24 weeks (Fig. 3E and Table 2). The
percentage of bone in the pores of BCP1200 was lower than that
in BCP1100, increasing from 2.462.2% at week 6 to 7.063.7%
and 10.964.2% at 12 and 24 weeks, respectively. Finally, the bone
tissue area in the pores of HA1200 was 8.565.9% and 8.866.4%
after 12 and 24 weeks, respectively. The area of osteoid tissue
inside the pores of samples that did not contain bone (for BCP1100
and BCP1200) was always below 1.5%.
Discussion
In the present study, we explored the dependence of
osteinductive potential of three calcium phosphate bioceramics
on their physicochemical properties and on the animal model in
which osteoinduction was studied. The three ceramics varied in
their chemical composition, microstructure or both as these
properties have previously been suggested to be of influence on the
osteoinductive potential [3,26,32,39,41,45]. To investigate the
effect of chemical composition, both phase-pure HA and biphasic
calcium phosphate ceramic consisting of HA and TCP were used.
In addition, BCP ceramic was sintered at either 1100uC or
1200uC, to vary surface microstructure in terms of grain size,
microporosity and surface area. The three ceramics were
implanted intramuscularly in rats, rabbits and dogs to obtain
information about the species-dependent ectopic bone formation.
While a number of studies exists in which synthetic biomaterials
were tested for their osteoinductive potential in various animal
models, in most of these studies one animal species was used as a
model, making the comparison among different studies difficult. In
studies where different animal species were used in parallel, either
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a low number of animals per time point was used [46] or bone
formation was assessed at a single time point [32]. Besides
variation among different species, variations in the amount of bone
induced in individuals from the same species have been reported,
making the sample size of such studies of great importance [23].
Earlier studies have shown that experiments involving 8–12 large
animals (goats, sheep, dogs) allow for a reliable comparison of
ectopic tissue formation by different materials [24]. Based on these
studies, and using a formula to estimate the minimum sample size
for our study design [44], we have selected the sample size for the
present study.
Physicochemical properties of osteoinductive materials such as
chemical composition, geometry, surface microstructure and
implant size have been reported as critical parameters for
successful osteoinductivity. As recently reviewed [39], in the past
decades, a large number of publications have illustrated osteoin-
duction by diverse biomaterials, such as synthetic and coral-
derived HA ceramics, a-TCP, b-TCP, BCP and calcium
phosphate cements (CPC). Besides calcium phosphate-containing
biomaterials, osteoinduction was also observed in alumina
ceramic, titanium and glass ceramics. However, so far most
biomaterials shown to be osteoinductive contained calcium
phosphate, which suggests the importance of calcium and
phosphate ions in the process of osteoinduction by biomaterials
[47–51]. When a biphasic calcium phosphate ceramic, consisting
of HA and b-TCP, was compared with a pure HA ceramic with
similar macro- and microstructure in a goat model, more bone was
found in BCP ceramic. This suggested that the more soluble
calcium phosphate phases are more osteoinductive than the less
soluble ones [3]. These results are in accordance with our findings,
where the biphasic ceramics (BCP1100, BCP1200) showed
significantly more osteoid tissue and/or bone than the phase-pure
HA (HA1200) in dogs (Fig. 3–7 and Table 2). Furthermore,
initiation of ectopic bone formation occurred earlier in biphasic
than in HA ceramic in dogs. While in rats and rabbits no bone
formation was found in any of the ceramics, the incidence of
osteoid tissue formation, believed to precede bone formation was
also more prominent in biphasic ceramic than in HA ceramic. The
proposed reasons for the observed positive effect of the more
soluble calcium phosphate ceramic on ectopic bone formation are
multiple, ranging from the sole effect of calcium release of
osteogenic differentiation of cells, to the process of dissolution/
reprecipitation of the biological apatite layer on the ceramic
surface, accompanied by the co-precipitation of endogenous
osteoinductive growth factors. In addition, the inflammatory
response (especially the chronic inflammation) induced by the
implanted ceramics and its solubility products (i.e. cytokines) may
also be an initiator of material-induced ectopic bone formation
[39,52–55].
Besides chemistry, structural features of the ceramics, at macro-
and micro level were suggested to influence osteoinductive
potential of biomaterials. For example, Ripamonti showed that
geometry is one of the crucial characteristics necessary for
rendering a biomaterial osteoinductive [20] and presence of
interconnected macropores was suggested to positively influence
ectopic bone formation by biomaterials [24,56,57]. In addition to
Figure 4. Histological evaluation of tissue formation in the three ceramics upon intramuscular implantation in rats, rabbits and
dogs. Representative images showing tissue response to BCP1100 (A, D, G), BCP1200 (B, E, H) and HA1200 (C, F, I) upon implantation in the femoral
muscle of rat, dorsal muscle of rabbit and dog for 6 weeks. Decalcified sections, HE Staining, magnification=6100, scale bar = 200 mm; VR Blood
vessel, CTRConnective tissue, MRMaterial, OROsteoid tissue, BRBone.
doi:10.1371/journal.pone.0107044.g004
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macroporosity, surface features like size of grains and presence of
micropores have also been proven important in the bone induction
process [58–61]. Micropores enlarge the surface area, which
facilitates ion exchange and bone-like apatite formation, and/or
accompanied binding of endogenous bone inducing proteins to the
surface, all of which may positively affect the adhesion, prolifer-
ation, and differentiation of the bone forming cells [23,62].
Furthermore, the microstructure of the materials has been shown
to directly influence cell shape and related signaling pathway, and
therewith also the final cell fate [63–65]. In the present study, BCP
sintered at a relatively low temperature of 1100uC (BCP1100),
having a larger specific surface area as well as more micropores
than BCP and HA sintered at 1200uC (BCP1200 and HA1200),
indeed showed relatively more bone formation than the other two
ceramics.
As previously mentioned, osteoinduction by biomaterials has
shown large interspecies differences, and numerous studies have
demonstrated that material induced bone formation is more likely
to occur in large animals [19–36,39,43] such as dogs, goats, sheep,
and non-human primates, than in rabbits [31,32], rats and mice
[32–34], as shown by Kurashina et al. [31] and Yuan et al. [32]
and confirmed by our study. While no bone formation was
observed in rats by any of the implanted materials, and bone
formation in rabbits was limited to BCP1100 and only a single
animal, osteoinduction in dogs occurred as early as after 6 weeks of
implantation in all the ceramics tested, though to a different extent
as demonstrated by histomorphometry (Table 2). Osteoid
formation occurred more frequently than bone formation,
however, its incidence was also largely dependent on both the
ceramic type and the species, following a trend similar to that of
bone formation dependence on material and species parameters:
increasing from rat to rabbit to dog for all ceramics and from
HA1200 to BCP1200 to BCP1100 in all animals. While incidence
of osteoid was in general higher than incidence of bone formation,
percentage of osteoid tissue inside the pores of the ceramics was
rather limited, though it should be mentioned that this analysis
was only performed on those samples that did not show any bone
formation. Based on these findings, it may be speculated that
osteoid formation is a precursor of bone formation during
osteoinduction by biomaterials, which in turn suggests surface
dynamics of dissolution and reprecipitation to play an important
role in this process.
The difference in the species-dependent osteoinductive potential
of the materials is not clear as yet, but it could plausibly be related
to various factors, such as genetic background and related
physiological metabolism of each species, including different
substance exchange, degradation and absorption kinetics, levels
of BMPs or other osteogenic factors available near the implants
and differences in response to osteogenic signals. In a recent study
by Barradas et al. [34], in which 11 mouse strains were compared,
reproducible ectopic bone formation upon subcutaneous implan-
tation of calcium phosphate ceramics was only found in one strain
(FVB mice), indeed suggesting the influence of genetic factors.
Besides interspecies variations in osteoinductive potential, also
differences in ectopic bone formation among individual animals of
the same species have been found in this study, comparable to the
Figure 5. Histological evaluation of tissue formation in the three ceramics upon intramuscular implantation in rats, rabbits and
dogs. Representative images showing tissue response to BCP1100 (A, D, G), BCP1200 (B, E, H) and HA1200 (C, F, I) upon implantation in the femoral
muscle of rat, dorsal muscle of rabbit and dorsal muscle of dog for 12 weeks. Decalcified sections, HE Staining, magnification=6100, scale
bar = 200 mm; VRBlood vessel, CTRConnective tissue, MRMaterial, OROsteoid tissue, BRBone.
doi:10.1371/journal.pone.0107044.g005
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differences among individuals reported earlier [23]. Both the
differences in the response of the species and the response of the
individuals from the same species may have important implica-
tions for the clinical use of these synthetic bone graft substitutes as
alternatives to natural bone grafts. The growing understanding of
the parameters that influence osteoinductive potential of bioma-
terials can be used to in design new materials, which may be
osteoinductive in smaller animals, like rats and mice as well.
With this study, in which we systematically analyzed effects of
physicochemical properties of calcium phosphate bioceramics in
three animal species and by using large numbers of samples, we
have shown that both presence of a more soluble b-TCP phase in
the ceramic and a decrease of sintering temperature that affects
surface microstructure of the ceramic positively influence its ability
to induce ectopic osteoid and bone formation. Furthermore, we
have demonstrated that material-induced ectopic bone formation
indeed reproducibly occurred in dogs, while in rats and rabbits,
only osteoid formation was observed.
Figure 6. Histological evaluation of tissue formation in the three ceramics upon intramuscular implantation in rats, rabbits and
dogs. Representative images, showing tissue response to BCP1100 (A, D, G), BCP1200 (B, E, H) and HA1200 (C, F, I) upon implantation in the femoral
muscle of rat, dorsal muscle of rabbit and dorsal muscle of dog for 24 weeks. Decalcified sections, HE Staining, magnification=6100, scale
bar = 200 mm; VRBlood vessel, CTRConnective tissue, MRMaterial, OROsteoid tissue, BRBone, BMRBone marrow.
doi:10.1371/journal.pone.0107044.g006
Figure 7. Histological evaluation of bone formation upon implantation of the three ceramics in dorsal muscles of dogs for 12
weeks. The highest amount of osteoid and ectopic bone were observed in BCP1100 (A), followed by BCP1200 (B) an HA1200 (C). In all cases, bone
was trabecular in appearance, with laminar bone and osteocytes contained in the lacunae, and infiltrated by blood vessels. Decalcified sections,
Masson’s trichrome staining, magnification=6100, scale bar = 200 mm; VRBlood vessel, CTRConnective tissue, MRMaterial, OROsteoid tissue,
BRBone.
doi:10.1371/journal.pone.0107044.g007
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Conclusion
The results of the present study showed that a BCP ceramic,
consisting of HA and TCP, that was sintered at a temperature of
1100uC showed more osteoid and/or bone formation upon
ectopic implantation than BCP (or HA) sintered at a higher
temperature (1200uC). Concerning the animal species, all tested
materials showed more ectopic osteoid and bone formation in dogs
than in rabbits or rats. In conclusion, this study demonstrated that
both, the type of calcium-phosphate ceramic and the animal
species influence the osteoinductive potential of the bioceramics.
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